Ignite Creation Date:
2025-12-24 @ 4:51 PM
Ignite Modification Date:
2026-03-31 @ 8:05 PM
Study NCT ID:
NCT01684150
Status:
COMPLETED
Last Update Posted:
2024-03-26
First Post:
2012-09-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 1, Open-Label, Dose-Escalation & Expanded Cohort, Continuous IV Infusion, Multi-center Study of the Safety, Tolerability,PK & PD of EPZ-5676 in Treatment Relapsed/Refractory Patients With Leukemias Involving
Sponsor:
Epizyme, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-09
Start Date Type:
None
Primary Completion Date:
2015-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-02
Completion Date Type:
ACTUAL
First Submit Date:
2012-09-06
First Submit QC Date:
None
Study First Post Date:
2012-09-12
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-03-24
Last Update Post Date:
2024-03-26
Last Update Post Date Type:
ACTUAL